Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd
The conference call may be accessed by dialing 1-888-317-6003 (Domestic US), 1-866-284-3684 (
As announced on
For more information about
Safe Harbor Statement
Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon our current expectations and projections about future events and generally relate to plans, objectives, and expectations for the development of our business, including the timing and progress of preclinical and clinical trials and discovery programs, the promise of the Company's portfolio of therapies, the Company's refocus to a healthcare-oriented business, and its continuing evaluation of options for the Company's non-healthcare businesses. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release. For a discussion of these risks and uncertainties, and other important factors, any of which could cause the Company's actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended
Investor Contact: Vice President, Investor Relations Tel: +1 (301) 556-9850 |
Corporate Contact: Vice President, Communications Tel: +1 (301) 556-9850 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/precigen-to-announce-fourth-quarter-and-full-year-2019-financial-results-on-march-2nd-301009637.html
SOURCE